Cargando…

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma

Lymphoma is a heterogeneous group of diseases that often require their metabolism program to fulfill the demand of cell proliferation. Features of metabolism in lymphoma cells include high glucose uptake, deregulated expression of enzymes related to glycolysis, dual capacity for glycolytic and oxida...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Yuyang, Lu, Tingxun, Xu-Monette, Zijun Y., Young, Ken H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052731/ https://www.ncbi.nlm.nih.gov/pubmed/36982568 http://dx.doi.org/10.3390/ijms24065493

Ejemplares similares

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma
por: Lu, Tingxun, et al.
Publicado: (2023)

Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma
por: Yu, Tiantian, et al.
Publicado: (2023)

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
por: Miao, Yi, et al.
Publicado: (2019)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
por: Ricci, Jean-Ehrland, et al.
Publicado: (2018)

Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia
por: Di Martino, Ludovica, et al.
Publicado: (2021)

Lipid metabolism reprogramming and its potential targets in cancer
por: Cheng, Chunming, et al.
Publicado: (2018)

Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
por: Van Wyngene, Lise, et al.
Publicado: (2018)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
por: Huang, Pengzhu, et al.
Publicado: (2023)

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma
por: Nguyen, Trang T. T., et al.
Publicado: (2022)

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
por: Shum, Hang Chee Erin, et al.
Publicado: (2023)

Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy
por: Zhang, Liufeng, et al.
Publicado: (2023)

Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets
por: Słotwiński, Robert, et al.
Publicado: (2021)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022)

Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer
por: Kujundžić, Renata Novak, et al.
Publicado: (2019)

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
por: Xu-Monette, Zijun Y., et al.
Publicado: (2017)

Metabolic reprogramming: the emerging concept and associated therapeutic strategies
por: Yoshida, Go J.
Publicado: (2015)

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
por: Gandhi, Nishant, et al.
Publicado: (2019)

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021)

Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma
por: Marabitti, Veronica, et al.
Publicado: (2022)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Targeting metabolic reprogramming in chronic lymphocytic leukemia
por: Nie, Yu, et al.
Publicado: (2022)

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up
por: Zhou, Hui, et al.
Publicado: (2020)

The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer
por: Duan, Sai-li, et al.
Publicado: (2023)

Photoreceptor metabolic reprogramming: current understanding and therapeutic implications
por: Pan, Warren W., et al.
Publicado: (2021)

Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Li, Yin, et al.
Publicado: (2021)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2022)

Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer
por: Nagayama, Yuji, et al.
Publicado: (2022)

Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
por: Li, Chunxia, et al.
Publicado: (2016)

Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path
por: Iessi, Elisabetta, et al.
Publicado: (2021)

Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis
por: Jing, Chenzhi, et al.
Publicado: (2020)

Metabolic reprogramming as a novel therapeutic target for Coxsackievirus B3
por: Kuk, Myeong Uk, et al.
Publicado: (2022)

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
por: Phan, Liem Minh, et al.
Publicado: (2014)

Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets
por: Kim, Lenise J., et al.
Publicado: (2020)

Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
por: Taubmann, Jule, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ao9ap6f4u2i5gdqqqe00eahlga